This standard uses high-performance liquid chromatography (HPLC) to analyze (2S, 3S)-dihydromyricetin and (2R, 3R)-dihydromyricetin in various dihydromyricetin raw materials with chemical purity ≥98%. Carry out analytical testing and content determination.
T/GDPA 1-2019 history
2022T/GDPA 1-2022 Reference catalogue of drug provisions in infirmary of enterprises and institutions
2021T/GDPA 1-2021 The specification of evidence-base pharmaceutical evaluation method for off-label drug use
2020T/GDPA 1-2020 Technical Specification of 3D Printing Subdivided Tablets in Medical Institutions
2019T/GDPA 1-2019 Determination of stereoisomers of Dihydromyricetin--High performance liquid chromatography method